BE893097A - Procede de preparation d'un polysulfate de chondroitine injectable, produit obtenu par ce procede et compositions pharmaceutiques le contenant - Google Patents

Procede de preparation d'un polysulfate de chondroitine injectable, produit obtenu par ce procede et compositions pharmaceutiques le contenant

Info

Publication number
BE893097A
BE893097A BE0/208024A BE208024A BE893097A BE 893097 A BE893097 A BE 893097A BE 0/208024 A BE0/208024 A BE 0/208024A BE 208024 A BE208024 A BE 208024A BE 893097 A BE893097 A BE 893097A
Authority
BE
Belgium
Prior art keywords
chondroitine
polysulfate
injectable
preparation
pharmaceutical compositions
Prior art date
Application number
BE0/208024A
Other languages
English (en)
Inventor
K H Wolf
Original Assignee
Luitpold Werk Chem Pharm
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Luitpold Werk Chem Pharm filed Critical Luitpold Werk Chem Pharm
Publication of BE893097A publication Critical patent/BE893097A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0069—Chondroitin-4-sulfate, i.e. chondroitin sulfate A; Dermatan sulfate, i.e. chondroitin sulfate B or beta-heparin; Chondroitin-6-sulfate, i.e. chondroitin sulfate C; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Materials Engineering (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Polymers & Plastics (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BE0/208024A 1981-05-11 1982-05-06 Procede de preparation d'un polysulfate de chondroitine injectable, produit obtenu par ce procede et compositions pharmaceutiques le contenant BE893097A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3118588A DE3118588C2 (de) 1981-05-11 1981-05-11 Verfahren zur Herstellung eines injizierbaren hochreinen Chondroitinpolysulfates, hiernach erhältliches Produkt und pharmazeutische Zusammensetzung

Publications (1)

Publication Number Publication Date
BE893097A true BE893097A (fr) 1982-08-30

Family

ID=6131969

Family Applications (1)

Application Number Title Priority Date Filing Date
BE0/208024A BE893097A (fr) 1981-05-11 1982-05-06 Procede de preparation d'un polysulfate de chondroitine injectable, produit obtenu par ce procede et compositions pharmaceutiques le contenant

Country Status (19)

Country Link
US (1) US4524066A (fr)
JP (1) JPS57192401A (fr)
AT (1) AT387225B (fr)
AU (1) AU552545B2 (fr)
BE (1) BE893097A (fr)
CA (1) CA1207758A (fr)
CH (1) CH650788A5 (fr)
DE (1) DE3118588C2 (fr)
DK (1) DK160317C (fr)
FI (1) FI70416C (fr)
FR (1) FR2505185B1 (fr)
GB (1) GB2098232B (fr)
IE (1) IE53633B1 (fr)
IL (1) IL65743A (fr)
IT (1) IT1157939B (fr)
LU (1) LU84143A1 (fr)
NL (1) NL186638C (fr)
NO (1) NO157147C (fr)
SE (1) SE458118B (fr)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3244214A1 (de) * 1982-11-30 1984-05-30 B. Braun Melsungen Ag, 3508 Melsungen Verfahren zur reinigung und fraktionierung von heparin
US4623539A (en) * 1983-02-04 1986-11-18 Tunc Deger C Nutrient barrier polysaccharide compositions and method of use
FR2572731B1 (fr) * 1984-11-07 1987-03-06 Sanofi Sa Nouveaux sulfates de xylanes de bas poids moleculaires, leur procede de preparation et leur activite antithrombotique et hypolipemiante par voie orale
IT1214609B (it) * 1985-05-17 1990-01-18 Opocrin Spa Esosaminoglicani solfati depolimerizzati ad attivita'antitrombotica, fibrinolitica, antinfiammatoria, loro procedimento di preparazione e composizioni farmaceutiche che li contengono.
US5668116A (en) * 1987-03-19 1997-09-16 Anthropharm Pty. Limited Anti-inflammatory compounds and compositions
AU604542B2 (en) * 1987-03-19 1990-12-20 Arthropharm Pty Ltd Polysulphated polysaccharide complexes
US5519010A (en) * 1989-02-06 1996-05-21 Taiho Pharmaceutical Co., Ltd. Sulfated polysaccharide, pharmaceutically acceptable salt thereof, process for preparing same and medicament containing same as effective component
ES2087907T3 (es) * 1989-02-06 1996-08-01 Taiho Pharmaceutical Co Ltd Nuevo polisacarido sulfatado, sales farmaceuticamente aceptables del mismo, procedimiento para prepararlos y medicamento que los contiene como ingrediente activo.
US5141928B1 (en) * 1989-12-20 1995-11-14 Brujo Inc Ophthalmic medication
JPH05279381A (ja) * 1991-09-13 1993-10-26 Dainippon Ink & Chem Inc 硫酸化オリゴ糖芳香族配糖体
IT1256236B (it) * 1992-12-23 1995-11-29 Mediolanum Farmaceutici Srl Oligosaccaridi aventi attivita' biologica e procedimento per la loro preparazione di glicosaminoglicani
US5880108A (en) * 1995-02-14 1999-03-09 Bioniche, Inc. Method for treating the internal urinary bladder and associated structures using hyaluronic acid
US5591724A (en) * 1995-02-14 1997-01-07 Bioniche Inc. Method for treating the urinary bladder and associated structures using hyaluronic acid
IN181358B (fr) * 1995-02-14 1998-05-30 Bioniche Inc
WO2000056298A2 (fr) * 1999-03-19 2000-09-28 Luitpold Pharmaceuticals, Inc. Traitement de la maladie de la lyme au moyen de formulations de glycosaminoglycans polysulfates
DK1625135T3 (da) * 2003-02-27 2009-06-22 Glaxo Group Ltd Fondaparinux-natrium af höj renhed
JP4679138B2 (ja) * 2004-12-24 2011-04-27 株式会社日本バリアフリー 高純度化されたムコ多糖類の製造方法
FR2969618B1 (fr) * 2010-12-28 2014-05-16 Pf Medicament Procede de preparation de chondroitine sulfate de sodium
RU2677330C2 (ru) * 2015-11-20 2019-01-16 Закрытое Акционерное Общество "Фармфирма "Сотекс" Способ приготовления инъекционной формы препарата хондроитина сульфата

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE136572C (fr) * 1902-12-05
DE870094C (de) * 1950-10-17 1953-03-09 Geigy Ag J R Verfahren zur Herstellung von Polyschwefelsaeureestern des Chondroitins
DE935843C (de) * 1951-07-12 1955-12-01 Hoffmann La Roche Verfahren zur Herstellung eines blutgerinnungshemmenden Mittels
US2767167A (en) * 1953-07-06 1956-10-16 Gen Mills Inc Process of reducing the viscosity of gums
DE968752C (de) * 1954-01-29 1958-03-27 Hoffmann La Roche Verfahren zur Herstellung von Chondroitinpolyschwefelsaeureestern
US2803558A (en) * 1956-06-27 1957-08-20 Commw Color & Chemical Co Method of treating adhesive gums
US2959583A (en) * 1959-01-23 1960-11-08 Warner Lambert Pharmaceutical Method of purifying sulfated polysaccharides
US3175942A (en) * 1962-03-13 1965-03-30 Evans Medical Ltd Gastro-intestinal therapeutic
US3174904A (en) * 1963-03-25 1965-03-23 Rexall Drug Chemical Method of purifying sulfated carbohydrates
US3405120A (en) * 1966-01-27 1968-10-08 Green Cross Corp Low molecular chondroitin sulfate and method for manufacturing the same
US3454560A (en) * 1966-03-01 1969-07-08 Seikagaku Kogyo Co Ltd Process for the production of chondroitin polysulfate
BE857389A (fr) * 1977-08-02 1977-12-01 Marbex Finance Ltd Procede de preparation de chondroitines-sulfates de metaux alcalins et alcalino-terreux d'un poids moleculaire de 3000 a 6000

Also Published As

Publication number Publication date
JPS57192401A (en) 1982-11-26
DK211882A (da) 1982-11-12
FI70416B (fi) 1986-03-27
FR2505185B1 (fr) 1986-02-28
US4524066A (en) 1985-06-18
NL186638C (nl) 1991-01-16
FI821651L (fi) 1982-11-12
DE3118588C2 (de) 1983-07-07
IE53633B1 (en) 1989-01-04
AT387225B (de) 1988-12-27
LU84143A1 (fr) 1982-09-13
FI821651A0 (fi) 1982-05-11
SE458118B (sv) 1989-02-27
DE3118588A1 (de) 1982-12-02
NO821551L (no) 1982-11-12
SE8202947L (sv) 1982-11-12
AU8357382A (en) 1982-11-18
IL65743A (en) 1985-09-29
SE8202947D0 (sv) 1982-05-11
FI70416C (fi) 1986-09-19
DK160317B (da) 1991-02-25
IL65743A0 (en) 1982-08-31
NL8201873A (nl) 1982-12-01
FR2505185A1 (fr) 1982-11-12
AU552545B2 (en) 1986-06-05
IE821127L (en) 1982-11-11
GB2098232B (en) 1985-02-13
DK160317C (da) 1991-08-05
NO157147B (no) 1987-10-19
ATA184282A (de) 1988-05-15
IT1157939B (it) 1987-02-18
CH650788A5 (de) 1985-08-15
CA1207758A (fr) 1986-07-15
GB2098232A (en) 1982-11-17
IT8221189A0 (it) 1982-05-11
JPH0261482B2 (fr) 1990-12-20
NL186638B (nl) 1990-08-16
NO157147C (no) 1988-01-27

Similar Documents

Publication Publication Date Title
FR2505185B1 (fr) Procede de preparation d'un polysulfate de chondroitine injectable, produit obtenu par ce procede et compositions pharmaceutiques le contenant
PT77488B (fr) Procede de preparation de derives de phenyl-1-piperidino-2-propanol et de compositions pharmaceutiques les contenant
FR2338271A1 (fr) Derives du phtalane, procede pour leur preparation, et compositions pharmaceutiques contenant de tels derives
FR2293928A1 (fr) Nouveaux derives d'acide 3-amino-indazolecarboxylique, leur procede de preparation et medicament les contenant
BE885812A (fr) Derives d'acides 6beta-hydroxyalkylpenicillaniques, leur procede de production et compositions pharmaceutiques les contenant
BE896724A (fr) Procede de traitement thermique d'une fraction de plasma, produit obtenu et composition pharmaceutique le contenant.
BE890574A (fr) Derive d'aminoalcoyl-furanne, procede pour sa preparation et composition pharmaceutique le contenant
PT78340A (fr) Procede de preparation de nouveaux derives de la tetrahydroxy- 3',4',5,7-flavone et des compositions pharmaceutiques les contenant
PT85279A (fr) Procede de preparation de derives du nitrofurane et de compositions pharmaceutiques les contenant
BE885385A (fr) Derives de d-6-n-propylergolines, leur procede de preparation et compositions pharmaceutiques en contenant
BE892552A (fr) Nouveaux amido-aminoacides, compositions pharmaceutiques les contenant et procede de preparation de ces amido-aminoacides
FR2292477A1 (fr) Derives de 1-amidoalkyl-4-sulfonyl-piperazine, leur procede d'obtention et medicaments contenant lesdits derives
FR2563519B1 (fr) Derives d'iminothiazolidine, procede pour leur preparation et compositions pharmaceutiques les contenant
BE824227A (fr) Nouveaux derives d'amidoxime, leur procede de prepatation ainsi que les compositions therapeutiques les contenant
PT77751B (fr) Procede de preparation de derives benzylideniques soufres et de compositions pharmaceutiques le contenant
BE864027A (fr) Procede de preparation de l'alpha-2,5,9-trimethylbenzo-(b)-thieno-(2,3,f)-morphane, produit obtenu et composition pharmaceutique le contenant
BE835744A (fr) Derives de 5,7-dihydroxytetraisoquinoline, procede pour leur preparation et compositions pharmaceutiques contenant de tels derives
BE875091A (fr) Derives de substitution de spirooxazolidinone steroidienne, leur procede de preparation et compositions pharmaceutiques les contenant
BE826711A (fr) Derives d'indolylacetylamino-acide, leur procede de preparation et les compositions pharmaceutiques contenant ces composes
FR2528422B1 (fr) Nouveaux derives du 1,2,3,4-tetrahydronaphtalene, procede pour leur preparation et composition pharmaceutique contenant ces derives
BE884716A (fr) Derives du 1,1,2-triphenylpropane et du 1,1,2-triphenylpropene procede de preparation de ces derives et compositions pharmaceutiques contenant ces nouveaux composes
FR2513994B1 (fr) Tripeptides anorexigenes, procede pour leur preparation et compositions pharmaceutiques les contenant
FR2315910A1 (fr) Compositions pharmaceutiques contenant de la " debrycine " heterocolloidale et procede pour leur preparation
PT75868A (fr) Procede de preparation de derives benzylideniques et de compositions pharmaceutiques les contenant
FR2529550B1 (fr) Derives d'acide apovincaminique, procede pour leur preparation et compositions pharmaceutiques contenant ces derives

Legal Events

Date Code Title Description
CN Change of patent owner's name
CA Change of address of the owner of the patent

Owner name: *LUITPOLD PHARMACEUTICALS INC.:ONE LUITPOLD DRIVE,

Effective date: 20011106

CH Change of patent owner

Owner name: *LUITPOLD PHARMACEUTICALS INC.

Effective date: 20011106

RE20 Patent expired

Owner name: LUITPOLD PHARMACEUTICALS INC.

Effective date: 20020506